Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
02/22/1996 | WO1996005209A2 Sialic acid/fucose based medicaments |
02/22/1996 | WO1996005203A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
02/22/1996 | WO1996005193A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
02/22/1996 | WO1996005181A1 Morpholine derivatives and their use as therapeutic agents |
02/22/1996 | WO1996005164A1 Anti-inflammatory preparation |
02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
02/22/1996 | WO1996004923A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
02/22/1996 | WO1996004787A1 Combined virustatic antimediator (covam) treatment of common colds |
02/22/1996 | CA2197336A1 Sialic acid/fucose based medicaments |
02/22/1996 | CA2197205A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
02/22/1996 | CA2196422A1 Anti-inflammatory preparation |
02/22/1996 | CA2196203A1 Combined virustatic antimediator (covam) treatment of common colds |
02/22/1996 | CA2195972A1 Morpholine derivatives and their use as therapeutic agents |
02/22/1996 | CA2195757A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
02/21/1996 | EP0479903B1 Substituted imidazoles useful as angiotensin ii blockers |
02/21/1996 | CN1117290A Bicyclic carboxylic acid leukotriene B4 antagonists |
02/21/1996 | CN1031053C Method for preparation of azaoxindole derivatives |
02/20/1996 | US5493030 5-substituted derivatives of mycophenolic acid |
02/20/1996 | US5493019 Useful as antiinflammatory and antiproliferative agents |
02/20/1996 | US5492927 Non-peptide tachykinin receptor antagonists to treat allergy |
02/20/1996 | US5492915 Substituted quinolyl compounds exhibiting selective leukotriene B4 antagonist activity |
02/20/1996 | US5492908 Antiarthritic |
02/20/1996 | US5492689 Administering simultaneously an antiviral agent and two antiinflammatory compounds; synergistic result in treatment of cold or influenza |
02/20/1996 | US5492314 Preloaded digressive rate mount |
02/20/1996 | CA1338077C Heterodimeric transforming growth factor-beta |
02/17/1996 | CA2156197A1 Composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effect in human beings and animals |
02/15/1996 | WO1996004280A1 Phenyl xanthine derivatives |
02/15/1996 | WO1996004266A2 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
02/15/1996 | WO1996004233A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
02/15/1996 | WO1996003999A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
02/15/1996 | WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives |
02/15/1996 | WO1996003982A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
02/15/1996 | WO1995032285A3 Transgenic arthritic mice |
02/15/1996 | WO1995031991A3 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
02/15/1996 | CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives |
02/15/1996 | CA2196193A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
02/15/1996 | CA2196183A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
02/15/1996 | CA2195850A1 Substituted indoles |
02/14/1996 | EP0696598A1 Polysaccharide esters and their salts |
02/14/1996 | EP0696456A2 Combination of necrosis inducing substances with substances which are activated by necrosis for the selective treatment of tumours and or inflammatory diseases |
02/14/1996 | EP0696287A1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
02/14/1996 | EP0696275A1 Vitamin d amide derivatives |
02/14/1996 | EP0696271A1 Cyclooxygenase and 5-lipoxygenase inhibiting hydroxamic acid derivatives |
02/14/1996 | EP0696199A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
02/14/1996 | CN1116824A Topical ketoconazole compositions |
02/14/1996 | CN1116822A Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
02/14/1996 | CN1116627A New peptides derived from trifluorumethylketones, process for their preparation and the pharmaceutical compositions which contain them |
02/14/1996 | CN1030999C Process for preparation of trypsin inhibitor |
02/13/1996 | US5491231 Hindered N-oxide esters of rapamycin |
02/13/1996 | US5491163 (Thia)cycloalkyl[B]indoles |
02/13/1996 | US5491158 Treating diseases of rheumatoid genesis |
02/13/1996 | US5491147 Tri-substituted phenyl derivatives and their use in pharmaceutical compositions and methods of treatment |
02/13/1996 | CA2035841C Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture |
02/08/1996 | WO1996003501A1 Dual hybrid system |
02/08/1996 | WO1996003430A1 Organic compounds |
02/08/1996 | WO1996003428A1 Antiprotozoal cyclic tetrapeptides |
02/08/1996 | WO1996003407A1 Compounds useful as antiproliferative agents and garft inhibitors |
02/08/1996 | WO1996003399A1 Dihydrobenzofuranes |
02/08/1996 | WO1996003396A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
02/08/1996 | WO1996003392A1 Substituted thiazoles for the treatment of inflammation |
02/08/1996 | WO1996003388A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
02/08/1996 | WO1996003387A1 4,5-substituted imidazolyl compounds for the treatment of inflammation |
02/08/1996 | WO1996003385A1 3,4-substituted pyrazoles for the treatment of inflammation |
02/08/1996 | WO1996003383A1 INDOLIZINE sPLA2 INHIBITORS |
02/08/1996 | WO1996003380A1 Aromatic amino ethers as pain relieving agents |
02/08/1996 | WO1996003376A1 1H-INDOLE-1-FUNCTIONAL sPLA2 INHIBITORS |
02/08/1996 | WO1996003371A1 N-acyl-n-(substituted cinnamoyl)ethylenediamine derivative |
02/08/1996 | WO1996003149A1 Antifungal-wound healing compositions and methods for preparing and using same |
02/08/1996 | WO1996003130A1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
02/08/1996 | WO1996003120A1 INDENE sPLA2 INHIBITORS |
02/08/1996 | CA2195847A1 Substituted thiazoles for the treatment of inflammation |
02/08/1996 | CA2195846A1 4,5-substituted imidazolyl compounds for the treatment of inflammation |
02/08/1996 | CA2195845A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
02/08/1996 | CA2195570A1 Indolizine spla2 inhibitors |
02/08/1996 | CA2195569A1 1h-indole-1-functional spla2 inhibitors |
02/08/1996 | CA2195432A1 Indene spla2 inhibitors |
02/08/1996 | CA2195123A1 3,4-substituted pyrazoles for the treatment of inflammation |
02/08/1996 | CA2194999A1 Antiprotozoal cyclic tetrapeptides |
02/08/1996 | CA2192088A1 Aromatic amino ethers as pain relieving agents |
02/08/1996 | CA2191603A1 Antifungal-wound healing compositions and methods for preparing and using same |
02/07/1996 | EP0695187A1 Compositions for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
02/07/1996 | EP0695185A1 New method of treatment |
02/07/1996 | EP0695179A1 Transdermal antiinflammatory composition |
02/07/1996 | EP0502049B1 Tumour necrosis factor antagonist |
02/07/1996 | CN1030920C Process for making mometasone furoate monohydrate |
02/07/1996 | CN1030890C Method for preparing a medicament compound |
02/06/1996 | US5489615 Pharmaceutical ointment being free from skin irritative action and a process for the preparation thereof |
02/06/1996 | US5489586 Method for treating inflammatory disease in humans |
02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
02/01/1996 | WO1996002545A1 Heterocycle-condensed morphinoid derivatives |
02/01/1996 | WO1996002544A1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
02/01/1996 | WO1996002541A1 8-aryl-1,6-naphthyridin-5-ones |
02/01/1996 | WO1996002506A1 Quinoline derivatives as leukotriene antagonists |
02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
02/01/1996 | WO1996002496A1 Novel chemical compound, its preparation and use as a drug |
02/01/1996 | WO1996002257A1 Antisense oligonucleotides of pleiotrophin |
02/01/1996 | WO1996002233A1 Immunological activity of rhamnolipids |
02/01/1996 | DE4426601A1 Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri Use of a combination product comprising a competitive progesterone antagonist and a progestin for the manufacture of a medicament for treating endometriosis or leiomyomata uteri of |